Task: Named Entity Recognition
Input (English): CONTEXT: Previous investigators have reported discrepancies between hematologic, marrow morphologic, and cytogenetic responses to imatinib mesylate among patients with chronic myeloid leukemia (CML).
Output (English): imatinib mesylate